APA (7th ed.) Citation

Corona-Montes, V., González-Cuenca, E., Fernández-Noyola, G., Olarte-Casas, M., Bobadilla-Salazar, D., Medrano-Urtecho, H., & Asimakopoulos, A. (2021). Primary lymph-node staging with 68Ga-PSMA PET in high-risk prostate cancer: Pathologic correlation with extended pelvic lymphadenectomy specimens. Urologic Oncology, 39(8), 494.e1. https://doi.org/10.1016/j.urolonc.2020.10.074

Chicago Style (17th ed.) Citation

Corona-Montes, V.E, E. González-Cuenca, G. Fernández-Noyola, M.A Olarte-Casas, D. Bobadilla-Salazar, H.M Medrano-Urtecho, and A.D Asimakopoulos. "Primary Lymph-node Staging with 68Ga-PSMA PET in High-risk Prostate Cancer: Pathologic Correlation with Extended Pelvic Lymphadenectomy Specimens." Urologic Oncology 39, no. 8 (2021): 494.e1. https://doi.org/10.1016/j.urolonc.2020.10.074.

MLA (9th ed.) Citation

Corona-Montes, V.E, et al. "Primary Lymph-node Staging with 68Ga-PSMA PET in High-risk Prostate Cancer: Pathologic Correlation with Extended Pelvic Lymphadenectomy Specimens." Urologic Oncology, vol. 39, no. 8, 2021, p. 494.e1, https://doi.org/10.1016/j.urolonc.2020.10.074.